A26A (p.Ala26Ala) variant of MAP2K1 (Q02750)
A26A (p.Ala26Ala) in MAP2K1 (Q02750) is a protein-truncating change. The available variant effect predictions contribute to a CATVariant prioritization score of 0.20 / 1. The record also includes population frequency data, experimental measurements, published literature, and structural context.
A26A (p.Ala26Ala) variant details
- p.Ala26Ala
- gnomAD 15-66387425-G-T
- Splice Region
- Variant Prioritization Score for Impact Estimate 0.198
- CADD 16.60
- Population evidence available
- Structural context available
- Dabrafenib and Cetuximab HT-29 cells, base editing z-scores (predicted consequen: score 0.108
- Literature evidence available